Private-equity firm Carlyle (CG) is in exclusive talks to acquire medical device maker Baxter’s kidney care spinoff Vantive for more $4B, including debt, according to The Wall Street Journal.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAX: